Valuation: Vitrolife AB

Market Cap 11.87B 1.24B 1.08B 1.01B 924M 1.74B 118B 1.77B 4.65B 58.97B 4.66B 4.56B 195B P/E 2026 *
24.1x
P/E 2027 * 19.5x
Enterprise Value 12.42B 1.3B 1.13B 1.05B 967M 1.82B 124B 1.85B 4.86B 61.7B 4.88B 4.77B 204B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.19x
Free-Float
54.39%
Yield 2026 *
1.26%
Yield 2027 * 1.44%
1 day+1.80%
1 week+2.51%
Current month+1.80%
1 month-3.79%
3 months-16.28%
6 months-4.62%
Current year-36.02%
1 week 85.6
Extreme 85.6
88.25
1 month 84
Extreme 84
101.9
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 2023-07-31
Director of Finance/CFO 55 2025-10-09
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 2013-04-18
Chairman 70 2023-07-31
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
2/6/26 Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+2.51%-37.88%-43.38% 1.22B
-1.95%+9.18%+283.46%+346.90% 21.74B
+4.56%+2.19%-41.78%-24.25% 9.36B
+1.56%-6.33%+43.39%+38.50% 6.49B
-0.55%+2.37%+259.40%-19.63% 6B
+0.17%+2.09%-11.61%-15.66% 5.57B
+4.15%+4.41%-41.80% - 4.43B
0.00%+12.05%-12.81%-23.15% 4.38B
-5.57%-10.70%+65.05%+81.04% 4.25B
+3.20%+7.08%-14.64%-35.31% 2.8B
Average +0.74%+2.45%+49.08%+33.90% 6.62B
Weighted average by Cap. +0.21%+3.84%+113.12%+120.54%

Financials

2026 *2027 *
Net sales 3.46B 361M 314M 293M 269M 508M 34.45B 516M 1.35B 17.18B 1.36B 1.33B 56.66B 3.71B 387M 337M 314M 289M 544M 36.93B 554M 1.45B 18.42B 1.46B 1.42B 60.75B
Net income 493M 51.48M 44.74M 41.77M 38.34M 72.3M 4.91B 73.56M 193M 2.45B 193M 189M 8.07B 609M 63.63M 55.3M 51.63M 47.39M 89.36M 6.06B 90.92M 238M 3.02B 239M 234M 9.98B
Net Debt 549M 57.39M 49.87M 46.56M 42.75M 80.6M 5.47B 82.01M 215M 2.73B 216M 211M 9B -26.74M -2.79M -2.43M -2.27M -2.08M -3.93M -266M -3.99M -10.47M -133M -10.5M -10.26M -438M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
26-08-03 SEK 87.65 +1.80% 127,971
26-07-31 SEK 86.10 -0.29% 120,557
26-07-30 SEK 86.35 -0.75% 172,895
26-07-29 SEK 87.00 +0.58% 245,976
26-07-28 SEK 86.50 +1.17% 183,084
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
87.65SEK
Average target price
129.60SEK
Spread / Average Target
+47.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock